Search Results - O. S. Shifrin

Refine Results
  1. 1
  2. 2

    Clinical features of chronic pancreatitis at elderly patients with severe mesenteric atherosclerosis by O. S. Shifrin, I. A. Sokolina, T. L. Lemina

    Published 2011-05-01

    Aim of investigation. To study clinical features of chronic pancreatitis in patients with severe mesenteric atherosclerosis (calcification of celiac trunk).Material and methods. Overall 290 patients with chronic pancreatitis have been investigated. According to alcoholic and biliary etiology of dise...

    Full description

    Get full text
    Article
  3. 3

    New Possibilities for the Treatment of Crohn’s Disease by Z. A. Mamieva, E. A. Poluektova, O. S. Shifrin

    Published 2019-12-01

    Aim. To review data on the efficiency and safety of using Ustekinumab in patients with Crohn’s disease.Key findings. Ustekinumab is a fully human monoclonal antibody of the IgG1k class to the p40 subunit of IL-12 and IL-23. The drug interrupts the cascade of humoral and cellular reactions leading to...

    Full description

    Get full text
    Article
  4. 4

    Intestinal Barrier, Permeability and Nonspecific Inflammation in Functional Gastrointestinal Disorders by A. L. Kovaleva, E. A. Poluektova, O. S. Shifrin

    Published 2020-09-01

    Aim of review. Description of intestinal mucosal barrier permeability disruption causes as morbid factors in gastrointestinal tract (GIT) functional disorders.General provisions. Intestinal mucosal barrier is composed of several elements: pre-epithelial barrier, a mucosal lining of epithelium; epith...

    Full description

    Get full text
    Article
  5. 5

    Short bowel syndrome: pathogenesis, clinical presentation and treatment by Anna F. Sheptulina, O. Z. Okhlobystina, O. S. Shifrin

    Published 2016-08-01

    Aim of review. To present basic information on the short bowel syndrome (SBS) Summary. Patients with the SBS are quite rare in practice of a clinician and, as a rule, require multidisciplinary approach. Most frequently disease manifests by malabsorption signs: diarrhea, weight loss, macro - and micr...

    Full description

    Get full text
    Article
  6. 6

    Surgical treatment of the fistulizing Crohn's disease with anterior abdominal wall reconstruction (Clinical case) by Yu. Ye. Kitsenko, O. S. Shifrin, P. V. Tsarkov

    Published 2018-08-01

    Aim of clinical case presentation. To discuss the consequences of erroneous management approach at suspicion for appendicular infiltrate, as well as options and difficulties of complicated Crohn’s disease treatment. Summary. Surgical treatment of fistulizing Crohn's disease with interorgan and...

    Full description

    Get full text
    Article
  7. 7

    Prevalence of Erosive-ulcerative Lesions of the Stomach and Helicobacter Pylori Infection in Patients with Ulcerative Colitis by N. A. Ponkratova, P. V. Pavlov, O. S. Shifrin

    Published 2019-06-01

    Aim. To assess the prevalence of erosive-ulcerative lesions of the gastric mucosa, as well as the frequency of Helicobacter pylori infection in patients with ulcerative colitis. Materials and methods. The study included 70 patients with ulcerative colitis. All patients, along with the standard exami...

    Full description

    Get full text
    Article
  8. 8

    Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder by E. A. Trush, E. A. Poluektova, A. G. Beniashvili, O. S. Shifrin

    Published 2023-02-01

    Aim: to demonstrate the management of a patient with somatization disorder and irritable bowel syndrome.Key points. A 41-yo female patient was admitted with complains of spastic lower abdomen pain, hard stool once every 1–2 days under laxative treatment (macrogol), bloating, anxiety, waiting for con...

    Full description

    Get full text
    Article
  9. 9

    Mesalazine use tactics in the ulcerative colitis patients by A. V. Korolev, O. Z. Okhlobystina, L. N. Androsova, O. S. Shifrin

    Published 2013-03-01

    Aim of the lecture. To specify indications for the administration of the 5-aminosalicylic acid (5-АSA) in the patients with ulcerative colitis (UC) and to discuss the possibility of correlation between the body mass index, the disease activity and reasonability for the prescription of the mesalazine...

    Full description

    Get full text
    Article
  10. 10

    Mechanisms of bacterial-to-host interaction and their disorders at inflammatory bowel diseases by Ye. A. Poluektova, O. S. Lyashenko, A. V. Korolev, O. S. Shifrin, V. T. Ivashkin

    Published 2014-11-01

    The aim of review. To discuss modern concepts on interaction of bacterial cells with human body, and disorders of micro-and macroorganism interaction at inflammatory bowel diseases (IBD).Summary. Quantitative and qualitative changes of intestinal microflora are revealed in patients with IBD, with te...

    Full description

    Get full text
    Article
  11. 11

    Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options by Ye. A. Poluektova, S. Yu. Kuchumova, O. S. Shifrin, A. A. Sheptulin, V. T. Ivashkin

    Published 2014-09-01

    The aim of review. To analyse of publications on qualitative and quantitative changes in pattern of intestinal microflora in patients with irritable bowel syndrome (IBS) and options of its treatment by pre-, pro-, and symbiotic drugs.Key points. In the last years more and more data appear on changes...

    Full description

    Get full text
    Article
  12. 12

    Modern methods of studying of human gastro-intestinal microflora by Ye. A. Poluektova, O. S. Lyashenko, O. S. Shifrin, A. A. Sheptulin, V. T. Ivashkin

    Published 2014-08-01

    The aim of review. To discuss modern concepts on the structure and functions of intestinal microflora and its possible effect on development of certain diseases, as well as the basic methods of diagnostics of disorders of its qualitative and quantitative structure.Key points. Intestinal microflora p...

    Full description

    Get full text
    Article
  13. 13

    Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases by Ye. A. Poluektova, Yu. O. Sidorina, S. Yu. Kuchumova, A. V. Korolev, O. S. Shifrin

    Published 2015-05-01

    The aim of review. To prove competency of application of probiotics and to analyze data of the original studies of efficacy of various probiotic agents in treatment of inflammatory bowel diseases (IBD).Summary. The role of microflora in pathogenesis of this group of diseases becomes more and more ob...

    Full description

    Get full text
    Article
  14. 14

    Efficacy of mesalazine at ulcerative colitis with nutritional failure by A. V. Korolyov, O. S. Shifrin, O. Z. Okhlobystina, L. N. Androsova, Yu. O. Sidorina

    Published 2015-03-01

    Aim of investigation. To specify relation between trophological status, severity of relapse of ulcerative colitis (UC) and efficacy of 5-aminosalicylic acid (5-ASA) for achievement of clinical remission.Summary. Nutritional status plays important role for body recovery at relapse of chronic diseases...

    Full description

    Get full text
    Article
  15. 15

    Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of const... by V. T. Ivashkin, O. M. Drapkina, A. A. Sheptulin, O. S. Shifrin, Ye. A. Poluektova, S. Yu. Kuchumova

    Published 2015-07-01

    Aim of investigation. To estimate effect of probiotics and enterokinetic agents on severity of clinical symptoms, presence of bacterial overgrowth syndrome (BOS) and quality of life of patients with constipation variant of irritable bowel syndrome (IBS-C).Material and methods. Comparative analysis o...

    Full description

    Get full text
    Article
  16. 16

    Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at d... by V. T. Ivashkin, O. M. Drapkina, A. A. Sheptulin, O. S. Shifrin, Ye. A. Poluektova, S. Yu. Kuchumova

    Published 2015-05-01

    Aim of investigation. To estimate effect of probiotics on severity of clinical symptoms, presence of bacterial overgrowth syndrome (BOS) and quality of life at diarrheal variant of irritable bowel syndrome (IBS-D).Material and methods. In 47 patients with diagnosis of IBS-D, confirmed by conformity...

    Full description

    Get full text
    Article
  17. 17

    Continuously relapsing (for two years) course of diarrheal variant of IBS (<i>Clinical case</i>) by Ye. A. Poluektova, S. Yu. Kuchumova, A. A. Kurbatova, A. A. Sheptulin, O. S. Shifrin, V. T. Ivashkin

    Published 2013-10-01

    The aim of the publication. By the example of clinical case to show modern algorithm of diagnostics and choice of pathogenically proved treatment for patient with continuously relapsing course of irritable bowel syndrome (IBS).Key points. Patient S., 20 years, has addressed in clinic with symptoms o...

    Full description

    Get full text
    Article
  18. 18

    Metabolic syndrome and pancreatic lesions by O. S. Shifrin, I. A. Sokolina, A. E. Leonovich, M. A. Ashitko, T. L. Lemina, A. V. Korolyov

    Published 2013-05-01

    Aim of investigation. To study features of pancreatic involvement in patients with metabolic syndromeMaterial and methods. Overall 720 patients were investigated who have admitted to the clinic with referral diagnosis «chronic pancreatitis» (CP). Of them steatosis of pancreas (SP) was diagnosed in 4...

    Full description

    Get full text
    Article
  19. 19

    Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Result... by V. T. Ivashkin, O. Z. Okhlobystina, M. V. Mayevskaya, O. S. Shifrin, Z. A. Mamieva, Yu. E. Azimova

    Published 2019-01-01

    Aim. This study is aimed at investigating the efficacy and safety of alimemazine (Teraligen®) therapy in patients with irritable bowel syndrome (IBS) associated with comorbid mental disorders (distress, anxiety, somatisation and depression).Materials and methods. During an open-label, non-comparativ...

    Full description

    Get full text
    Article
  20. 20

    Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis by E. A. Trush, A. E. Karchevskaya, R. V. Maslennikov, E. A. Poluektova, O. S. Shifrin, V. T. Ivashkin

    Published 2024-08-01

    Introduction. Genetic predisposition in combination with environmental factors and the patient’s psychological and emotional state play a key role in the development of irritable bowel syndrome (IBS). Studies of association between genetic polymorphisms and IBS can help in understanding the key path...

    Full description

    Get full text
    Article